Literature DB >> 2042597

Stereotactic brain biopsy in the diagnosis of malignant lymphoma.

M E Sherman1, Y S Erozan, R B Mann, A A Kumar, J C McArthur, W Royal, S Uematsu, H J Nauta.   

Abstract

Fifteen patients with cerebral involvement by malignant non-Hodgkin's lymphoma were identified, among more than 200 patients who underwent stereotactic biopsy at The Johns Hopkins Hospital. All but one of these cases were diagnosed accurately by the stereotactic biopsy procedure. In 12 of 14 patients, the material was adequate to classify the lymphoma according to the Working Formulation. Because all but one of the lesions were intermediate or high-grade neoplasms, a diagnosis of lymphoma was often possible by conventional light microscopic examination alone. Monotypic light chain expression was demonstrated by immunohistochemical techniques in six patients, and positivity for B-cell markers was observed in an additional case. In one instance, two stereotactic biopsy specimens were interpreted as being suggestive of lymphoma, but necrosis and inflammation prevented a definitive diagnosis. Nine patients had no known risk factors for cerebral lymphoma, and the diagnosis often was unsuspected clinically.

Entities:  

Mesh:

Year:  1991        PMID: 2042597     DOI: 10.1093/ajcp/95.6.878

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature.

Authors:  B Pirotte; M Levivier; S Goldman; J M Brucher; J Brotchi; J Hildebrand
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

2.  Differentiation of Enhancing Glioma and Primary Central Nervous System Lymphoma by Texture-Based Machine Learning.

Authors:  P Alcaide-Leon; P Dufort; A F Geraldo; L Alshafai; P J Maralani; J Spears; A Bharatha
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-27       Impact factor: 3.825

Review 3.  A systematic approach to the diagnosis of suspected central nervous system lymphoma.

Authors:  Brian J Scott; Vanja C Douglas; Tarik Tihan; James L Rubenstein; S Andrew Josephson
Journal:  JAMA Neurol       Date:  2013-03-01       Impact factor: 18.302

Review 4.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 5.  Blood brain barrier: a challenge for effectual therapy of brain tumors.

Authors:  Arijit Bhowmik; Rajni Khan; Mrinal Kanti Ghosh
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.